Virax Biolabs Group Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '25 May 23, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	4	2	11	-	-	-
Market Cap Growth	44.87%	-84.34%	-	-	-	-
Enterprise Value	-2	-4	6	-	-	-
Last Close Price	1.00	0.72	6.95	-	-	-
PS Ratio	31.47	10.83	1262.87	-	-	-
PB Ratio	0.50	0.33	1.21	-	-	-
P/TBV Ratio	0.50	0.32	1.21	-	-	-
EV/Sales Ratio	-	-	701.38	-	-	-
Debt / Equity Ratio	0.07	0.04	0.02	-	-0.21	-0.62
Asset Turnover	0.01	0.02	0.00	-	3.98	-
Inventory Turnover	0.27	0.64	0.44	-	-	-
Quick Ratio	10.67	23.01	10.35	0.02	0.02	0.02
Current Ratio	11.58	25.94	10.61	0.04	0.05	0.02
Return on Equity (ROE)	-90.64%	-95.98%	-141.63%	-	-	-
Return on Assets (ROA)	-47.66%	-49.90%	-72.67%	-2453.52%	-1294.67%	-
Return on Capital (ROIC)	-51.27%	-52.89%	-91.03%	-	-	-
Earnings Yield	-151.55%	-397.61%	-50.48%	-	-	-
FCF Yield	-121.59%	-425.13%	-38.66%	-	-	-
Buyback Yield / Dilution	-50.43%	-88.75%	-11.15%	-297.67%	-130.43%	-

Updated Nov 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q